SLC38A3
Basic information
Region (hg38): 3:50205246-50221486
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 35.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
NM_006841.6 | NP_006832.1 | 15 | yes | - |
ENST00000614032.5 | ENSP00000481301.1 | 15 | yes | - |
ENST00000610458.4 | ENSP00000479737.1 | 3 | - | - |
ENST00000445096.5 | ENSP00000480466.1 | 7 | - | - |
Phenotypes
GenCC
Source:
- developmental and epileptic encephalopathy 102 (Moderate), mode of inheritance: AR
- developmental and epileptic encephalopathy 102 (Strong), mode of inheritance: AR
- developmental and epileptic encephalopathy 102 (Strong), mode of inheritance: AR
- developmental and epileptic encephalopathy 102 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Developmental and epileptic encephalopathy 102 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic; Ophthalmologic | 34605855 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (54 variants)
- Developmental_and_epileptic_encephalopathy_102 (8 variants)
- Short_stature (3 variants)
- not_provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC38A3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_006841.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | ||||
| missense | 1 | 57 | 3 | 61 | ||
| nonsense | 2 | 1 | 3 | |||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 6 | 1 | 58 | 3 | 0 |
Highest pathogenic variant AF is 0.000001373234
GnomAD
Source:
dbNSFP
Source:
- Function
- FUNCTION: Sodium-dependent amino acid/proton antiporter. Mediates electrogenic cotransport of glutamine and sodium ions in exchange for protons. Also recognizes histidine, asparagine and alanine. May mediate amino acid transport in either direction under physiological conditions. May play a role in nitrogen metabolism and synaptic transmission. {ECO:0000250|UniProtKB:Q9JHZ9, ECO:0000269|PubMed:10823827}.;
- Pathway
- GABAergic synapse - Homo sapiens (human);Glutamatergic synapse - Homo sapiens (human);Proximal tubule bicarbonate reclamation - Homo sapiens (human);Amino acid transport across the plasma membrane;Amino acid and oligopeptide SLC transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Histidine metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Aminosugars metabolism;Glycine, serine, alanine and threonine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.182
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.731
Gene ontology
- Biological process
- amino acid transmembrane transport;sodium ion transport;amino acid transport;asparagine transport;glutamine transport;brain development;female pregnancy;L-alanine transport;histidine transport;cellular response to potassium ion starvation;positive regulation of transcription from RNA polymerase II promoter in response to acidic pH;L-histidine transmembrane transport;positive regulation of glutamine transport
- Cellular component
- plasma membrane;integral component of plasma membrane;basolateral plasma membrane
- Molecular function
- L-histidine transmembrane transporter activity;amino acid transmembrane transporter activity;L-alanine transmembrane transporter activity;L-asparagine transmembrane transporter activity;L-glutamine transmembrane transporter activity;symporter activity;antiporter activity